MacroGenics shares climb following $80M IPO

Print
Font Size:
Default font size
Larger font size

Posted: Thursday, October 10, 2013 12:00 am

NEW YORK (AP) - Shares of MacroGenics are surging in Thursday midday trading after the biotechnology company raised $80 million in its initial public offering.

MacroGenics sold 5 million shares of stock for $16 per share. It had expected to sell 4 million shares for $14 to $16 each. The $80 million total does not include expenses or underwriting discounts.

The stock is up $8.50, or 53 percent, to $25.50, and earlier traded as high as $26.36..

Shares of MacroGenics Inc. are now trading on the Nasdaq Global Select Market under the ticker symbol "MGNX."

The Rockville, Md., company is developing monoclonal antibody-based therapeutics for the treatment of cancer and autoimmune diseases. It does not have any approved drugs and its most advanced experimental drug is in mid-stage clinical testing.

© 2014 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.


loading...

SPOTLIGHT »

Inside Business
To submit an announcement for "Inside Business", click here. For questions call (402) 444-1371 or e-mail announcements@owh.com.

World-Herald Alerts

Want to get World-Herald stories sent directly to your home or work computer? Sign up for Omaha.com's News Alerts and you will receive e-mails with the day's top stories.